Financhill
Back

NuCana PLC Vs. Biodexa Pharmaceuticals Plc Industry Stock Comparison

Sell
42

NCNA
NuCana PLC

Last Price:
2.65
Seasonality Move:
-12.75%
Sell
42

BDRX
Biodexa Pharmaceuticals Plc

Last Price:
0.90
Seasonality Move:
-1.3%
Sell
42
NuCana PLC (NCNA) is a Sell

Is NuCana PLC a Buy, Sell or Hold?

  • The current NuCana PLC [NCNA] share price is $2.77. The Score for NCNA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NCNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Biodexa Pharmaceuticals Plc (BDRX) is a Sell

Is Biodexa Pharmaceuticals Plc a Buy, Sell or Hold?

  • The current Biodexa Pharmaceuticals Plc [BDRX] share price is $0.89. The Score for BDRX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • BDRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NCNA Stock Price Chart

What is NuCana PLC's stock price today?

  • The NuCana PLC share price today is $2.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NCNA is experiencing buying pressure, which is a positive indicator for future bullish movement.

BDRX Stock Price Chart

What is Biodexa Pharmaceuticals Plc's stock price today?

  • The Biodexa Pharmaceuticals Plc share price today is $0.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDRX is experiencing slight buying pressure.

NCNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 34.51 Sell
Chaikin Money Flow: 5001 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.81 - 3.45) Sell
Bollinger Bands (100): (3.18 - 7.68) Sell

BDRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 44.61 Sell
Chaikin Money Flow: 42635 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.91 - 1.03) Sell
Bollinger Bands (100): (0.88 - 1.4) Sell

NCNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.8 Sell
20-day SMA: 3.02 Sell
50-day SMA: 3.46 Sell
200-day SMA: 8.19 Sell
8-day EMA: 2.79 Sell
20-day EMA: 3.01 Sell
50-day EMA: 3.74 Sell
200-day EMA: 8.6 Sell

BDRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.92 Sell
20-day SMA: 0.96 Sell
50-day SMA: 1.05 Sell
200-day SMA: 2.22 Sell
8-day EMA: 0.91 Sell
20-day EMA: 0.96 Sell
50-day EMA: 1.05 Sell
200-day EMA: 28.3 Sell

NuCana PLC Earnings Growth & NCNA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.84 per share, an increase next quarter of $0.09 per share, an increase this year of $2.64 per share, and a decrease next year of $3.67 per share.

Biodexa Pharmaceuticals Plc Earnings Growth & BDRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.05 per share.

NuCana PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biodexa Pharmaceuticals Plc Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):